Blueprint Medicines(BPMC) - 2024 Q2 - Earnings Call Presentation

Second Quarter 2024 Financial Results AUG 1, 2024 Agenda INTRODUCTION AYVAKIT PERFORMANCE Kate Haviland Chief Executive Officer Philina Lee, PhD Chief Commercial Officer CORPORATE PROGRESS Christy Rossi Chief Operating Officer Q2 2024 FINANCIAL PERFORMANCE Mike Landsittel Chief Financial Officer Not for promotional use 2 Forward-looking statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without l ...